Search results
Decoding BeiGene Ltd (BGNE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoThreats Intense Competition in Oncology: The oncology pharmaceutical landscape is highly...
PolyPid Ltd. (NASDAQ:PYPD) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 9 hours agoPolyPid Ltd. (NASDAQ:PYPD) Q1 2024 Earnings Call Transcript May 9, 2024 PolyPid Ltd. isn’t one of...
BeiGene shares edge up on narrower-than-expected loss in Q1, revenue beat
Investing.com· 3 days agoBeiGene , Ltd. (NASDAQ: BGNE ), a global biotechnology company focused on developing innovative...
Sciwind Biosciences and HK inno.N Corporation Announce Licensing and Partnership Agreement for...
WROC Rochester· 4 days agoSciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing ...
Kamada Ltd. Forecasted to Post Q2 2024 Earnings of $0.05 Per Share (NASDAQ:KMDA)
ETF DAILY NEWS· 24 hours agoKamada Ltd. (NASDAQ:KMDA – Free Report) – Equities researchers at HC Wainwright decreased their Q2 2024 earnings per share (EPS) estimates for Kamada in a note issued to investors ...
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by...
The Arab Tribune· 2 days agoThe incidence of pancreatic cancer is increasing globally, which is driving the growth of the market. As of 2023, the American Cancer Society predicts that 64,050 Americans will be diagnosed ...
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Zacks· 2 days agoCatalyst (CPRX) reports first-quarter results, wherein earnings and revenues beat the Zacks Consensus Estimate, driven by strong Firdapse sales.
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
WRBL Columbus· 1 day agoSN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), ...
Seaport Res Ptn Weighs in on FMC Co.’s Q2 2024 Earnings (NYSE:FMC)
ETF DAILY NEWS· 5 hours agoFMC Co. (NYSE:FMC – Free Report) – Stock analysts at Seaport Res Ptn dropped their Q2 2024 earnings per share estimates for FMC in a research report issued to clients and investors on Wednesday ...
Recce Pharmaceuticals makes breakthrough in lung infection treatment with nebulised RECCE® 327
Proactive Investors· 2 days agoRecce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has received promising results from a pilot study...